| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 12 |
| 1 | PANITUMUMAB | 12 |
| 2 | FLUOROURACIL | 10 |
| 3 | FLUOROURACIL CREAM, 0.5% | 10 |
| 4 | CAPECITABINE | 8 |
| 5 | TRASTUZUMAB | 6 |
| 6 | MACITENTAN | 5 |
| 7 | NIRAPARIB | 5 |
| 8 | ASPIRIN | 4 |
| 9 | ASPIRIN 325 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FUTIBATINIB | 1 | 0.0045 |
| 1 | NITROFURANTOIN (MACROCRYSTALS) | 1 | 0.0016 |
| 2 | PANITUMUMAB | 12 | 0.0007 |
| 3 | BEVACIZUMAB-AWWB | 2 | 0.0004 |
| 4 | RITUXIMAB-ABBS | 2 | 0.0004 |
| 5 | TRIFLURIDINE AND TIPIRACIL | 4 | 0.0004 |
| 6 | TELOTRISTAT ETHYL | 2 | 0.0003 |
| 7 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 8 | LANREOTIDE ACETATE | 2 | 0.0003 |
| 9 | NIRAPARIB | 5 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 14 | 0.0003 |
| 1 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 2 | Bile Acid [EPC] | 3 | 0.0001 |
| 3 | Vitamin K [EPC] | 1 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 22 | 0.0001 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 6 | 0.0001 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 8 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 9 | Nucleoside Analog Antiviral [EPC] | 5 | 0.0001 |